Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Allogeneic bone marrow transplantation for Alexander’s disease

Abstract

In this case report, we evaluate the efficacy of allogeneic bone marrow transplantation (BMT) in a 7-month-old female with the infantile form of Alexander’s disease. Based on research that describes Alexander’s disease as a leukodystrophy which may result from an unidentified enzyme deficiency, we attempted marrow transplantation to reverse or arrest the patient’s neurological deterioration. Despite an initial return to her pretransplant neurological state, the patient’s neurological status deteriorated. Marrow transplantation was not effective in changing her prognosis with Alexander’s disease.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Staba, MJ., Goldman, S., Johnson, F. et al. Allogeneic bone marrow transplantation for Alexander’s disease. Bone Marrow Transplant 20, 247–249 (1997). https://doi.org/10.1038/sj.bmt.1700871

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1700871

Keywords

Search

Quick links